Medication Overuse Headache

被引:0
作者
Valerie Cheung
Farnaz Amoozegar
Esma Dilli
机构
[1] University of British Columbia,Gordon and Leslie Diamond Health Center
[2] University of Calgary,8219
来源
Current Neurology and Neuroscience Reports | 2015年 / 15卷
关键词
Medication overuse headache; Rebound headache; Chronic daily headache; Opioids; Triptans; Combination analgesics; NSAIDS;
D O I
暂无
中图分类号
学科分类号
摘要
Medication overuse headache (MOH) is a common and disabling headache disorder. It has a prevalence of about 1–2 % in the general population. The International Classification of Headache Disorders 3rd edition (beta version) has defined MOH as a chronic headache disorder in which the headache occurs on 15 or more days per month due to regular overuse of medication. These headaches must have been present for more than 3 months. The pathophysiology is complex and not completely known. It involves genetic and behavioural factors. There is evidence that cortical spreading depression, trigeminovascular system and neurotransmitters contribute to the pain pathway of MOH. The treatment of MOH includes patient education, stopping the offending drug(s), rescue therapy for withdrawal symptoms and preventative therapy. Relapse rates for MOH are high at 41 %. MOH can severely impact quality of life, so it is important to identify patients who are at risk of analgesic overuse.
引用
收藏
相关论文
共 247 条
  • [31] Holmen TL(1996)Platelet serotonin in patients with analgesic-induced headache Cephalalgia 16 423-2
  • [32] Zwart JA(1993)5HT in migraine patients with medication-induced headache Cephalalgia 13 410-22
  • [33] Wang SJ(1996)Serotonin receptor adaptation in patients with analgesic-induced headache Cephalalgia 16 419-12
  • [34] Fuh JL(2008)Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans J Headache Pain 9 109-97
  • [35] Lu SR(2010)Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache Headache 50 185-8
  • [36] Juang KD(2008)Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels Eur J Clin Pharmacol 64 1-61
  • [37] Lu SR(2012)Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trondelag Health Studies Pain 153 56-7
  • [38] Fuh JL(2013)Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder Neurol Sci 34 S175-54
  • [39] Chen WT(2012)The bidirectional relationship between headache and chronic musculoskeletal complaints: an 11-year follow-up in the Nord-Trondelag Health Study (HUNT) Eur J Neurol 19 1447-9
  • [40] Juang KD(2002)Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway Cephalalgia 22 672-68